Eli Lilly LLY
SEC filings (XBRL) · quarterly · fiscal year ends December 31
Pick a second metric to compare.
Source: SEC EDGAR 10-Q/10-K XBRL, CIK 59478; every value is traced to its filing on EDGAR. Retrieved Oct 11, 2026. Quarters labelled by fiscal quarter with the calendar period end. Q4 = annual minus Q1–Q3; cash-flow quarters derived from year-to-date figures.
Last 84 quarters
| Q3 2024Sep 30, 2024 | Q4 2024Dec 31, 2024 | Q1 2025Mar 31, 2025 | Q2 2025Jun 30, 2025 | Q3 2025Sep 30, 2025 | Q4 2025Dec 31, 2025 | Q1 2026Mar 31, 2026 | Q2 2026Jun 30, 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.4B | $13.5B | $12.7B | $15.6B | $17.6B | $19.3B | $19.8B | $23.0B |
| Operating income | — No figure for Q2 2009–Q2 2026: Income statement has no operating-income subtotal; no us-gaap:OperatingIncomeLoss fact in any filing. | — No figure for Q2 2009–Q2 2026: Income statement has no operating-income subtotal; no us-gaap:OperatingIncomeLoss fact in any filing. | — No figure for Q2 2009–Q2 2026: Income statement has no operating-income subtotal; no us-gaap:OperatingIncomeLoss fact in any filing. | — No figure for Q2 2009–Q2 2026: Income statement has no operating-income subtotal; no us-gaap:OperatingIncomeLoss fact in any filing. | — No figure for Q2 2009–Q2 2026: Income statement has no operating-income subtotal; no us-gaap:OperatingIncomeLoss fact in any filing. | — No figure for Q2 2009–Q2 2026: Income statement has no operating-income subtotal; no us-gaap:OperatingIncomeLoss fact in any filing. | — No figure for Q2 2009–Q2 2026: Income statement has no operating-income subtotal; no us-gaap:OperatingIncomeLoss fact in any filing. | — No figure for Q2 2009–Q2 2026: Income statement has no operating-income subtotal; no us-gaap:OperatingIncomeLoss fact in any filing. |
| Net income | $1.0B | $4.4B | $2.8B | $5.7B | $5.6B | $6.6B | $7.4B | $7.1B |
| Capital spending | $1.4B | $1.5B | $1.5B | $1.7B | $2.1B | $2.5B | $2.3B | $2.9B |
| Operating cash flow | $3.7B | $2.5B | $1.7B | $3.1B | $8.8B | $3.2B | $5.3B | $10.7B |
| Free cash flow | $2.4B | $1.0B | $0.2B | $1.4B | $6.7B | $0.7B | $3.0B | $7.8B |
| Capex / operating cash flow | 36.4% | 60.5% | 90.6% | 55.0% | 23.6% | 79.0% | 43.6% | 27.4% |
| Shares outstanding | 949.3M | 948.2M | 947.7M | 946.5M | 945.4M | 943.4M | 941.7M | 941.4M |
| Share count change, y/y | +0.0% | −0.2% | −0.3% | −0.4% | −0.4% | −0.5% | −0.6% | −0.5% |
| Diluted shares (weighted avg.) | 905.0M | — No figure for Q4 2024: Fiscal Q4: the 10-K gives only the 12-month weighted average; a quarterly weighted average cannot be derived by subtraction. | 900.6M | 899.8M | 898.8M | — No figure for Q4 2025: Fiscal Q4: the 10-K gives only the 12-month weighted average; a quarterly weighted average cannot be derived by subtraction. | 895.9M | 893.7M |
Operating income: Not presented by the company: Income statement has no operating-income subtotal; no us-gaap:OperatingIncomeLoss fact in any filing..
— Diluted shares (weighted avg.): No figure for Q4 2024: Fiscal Q4: the 10-K gives only the 12-month weighted average; a quarterly weighted average cannot be derived by subtraction.
— Diluted shares (weighted avg.): No figure for Q4 2025: Fiscal Q4: the 10-K gives only the 12-month weighted average; a quarterly weighted average cannot be derived by subtraction.
Diluted shares (weighted avg.): fiscal Q4 is blank because the 10-K gives 12-month figures only; some quarters blank: No 3-month diluted weighted-average value in XBRL for this quarter.
† Amended filing: Shares outstanding, Q2 2010. Cover from 10-Q/A filed 2010-08-02, which amends the original filing for the same period; original 10-Q cover showed 1,153,140,541. 10-Q/A on EDGAR
XBRL tags used
| Revenue | Revenues | Jun 2009 to Jun 2026 |
|---|---|---|
| Operating income | Not presented by the company: Income statement has no operating-income subtotal; no us-gaap:OperatingIncomeLoss fact in any filing. | |
| Net income | NetIncomeLoss | Jun 2009 to Jun 2026 |
| Capital spending | PaymentsToAcquireOtherPropertyPlantAndEquipment | Mar 2022 to Jun 2026 |
| Operating cash flow | NetCashProvidedByUsedInOperatingActivities | Jun 2009 to Jun 2026 |
| Free cash flow | ocf - capex: NetCashProvidedByUsedInOperatingActivities, PaymentsToAcquireOtherPropertyPlantAndEquipment | Mar 2022 to Jun 2026 |
| Capex / operating cash flow | capex / ocf * 100: PaymentsToAcquireOtherPropertyPlantAndEquipment, NetCashProvidedByUsedInOperatingActivities | Mar 2022 to Jun 2026 |
| Shares outstanding | dei:EntityCommonStockSharesOutstanding | Jun 2009 to Jun 2026 |
| Diluted shares (weighted avg.) | WeightedAverageNumberOfDilutedSharesOutstanding | Mar 2013 to Jun 2026 |
Where a company changed tags, each quarter uses the tag it was reported under; the newest tag is primary.